Sharad Mansukani - 14 Sep 2021 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Director
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Sep 2021
Net transactions value
-$4,371,875
Form type
4
Filing time
15 Sep 2021, 17:20:23 UTC
Previous filing
15 Jun 2021
Next filing
30 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $156,250 +156,250 +13% $1.00 1,385,606 14 Sep 2021 Direct F1
transaction AGL Common Stock Sale $4,528,125 -156,250 -11% $28.98 1,229,356 14 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -156,250 -24% $0.000000 493,750 14 Sep 2021 Common Stock 156,250 $1.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 These options were granted on April 27, 2017, and fully vested on July 1, 2020.